| Hazard Information | Back Directory | [Uses]
SB03178 is a fibroblast activation protein-alpha (FAP) inhibitor. SB03178 can be conjugated with DOTA and can be used for cancer research[1]. | [References]
[1] Bendre S, et al. Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy. Eur J Med Chem. 2024 Feb 13;268:116238. DOI:10.1016/j.ejmech.2024.116238 |
|
|